Treatment will proceed betting huge on Alan Wake and Control in 2026 after its first try at a self-published spinoff, FBC: Firebreak, didn’t set the world alight.
In its fiscal report for the yr ended December 31, 2025, the Finnish studio revealed Control has now offered over 5 million copies worldwide. That milestone was reached after the title generated 1 million sales in 2025.
In whole, the supernatural shooter has attracted over 20 million players since launching in August 2019 because of its inclusion on subscription providers like Xbox Sport Move and PlayStation Plus—in addition to different partnerships.
Treatment informed buyers it needs to capitalize on the success of Control by guaranteeing its recently-announced sequel, Control Resonant, is considered as a “must-have day-one buy” for followers of the unique.
“Launch-window is vital for a recreation’s business success, and we wish to seize the momentum,” reads the corporate’s earnings presentation. “We wish to have a spectacular product out on launch.”
The studio mentioned the announcement of Control Resonant at The Sport Awards in December 2025 supplied a “significant increase” to sales of the unique. The sequel is at the moment slated to launch in 2026—although Treatment hasn’t confirmed a exact date or window.
Treatment welcomes ‘optimistic and worthwhile’ fourth-quarter after tough yr
Discussing the efficiency of its different titles, Treatment mentioned Alan Wake 2 proceed to promote nicely whereas producing platform-deal royalties after being featured as a month-to-month recreation on PlayStation Plus in October 2025.
As for FBC: Firebreak, the underperforming multiplayer shooter self-published by Treatment, the corporate mentioned participant counts stay on a “secure however low degree.” The corporate will proceed supporting the title with “smaller updates” in 2026.
Elsewhere, the Max Payne 1 & 2 remake stays in full manufacturing whereas a thriller ‘new mission’ has entered the proof-of-concept part.
So, how did Treatment finish what it conceded was a difficult yr? Interim CEO Markus Mäki, who will probably be changed by former EA exec Jean-Charles Gaudechon in March, defined This fall was “optimistic and worthwhile.”
“Within the fourth quarter of 2025, Treatment’s income elevated by 46.3 % from the comparability interval and was €17.0 million. Sport sales and royalties saved on growing in the course of the fourth quarter of 2025 and shaped nearly half of the whole income for This fall 2025, the main contributors being royalties from Alan Wake 2 and recreation sales of Control,” he added.
“Growth charges have been from Max Payne 1 & 2 remake and CONTROL Resonant. EBITDA was €3.9 million. Working revenue (EBIT) was €0.7 million. The development in profitability within the fourth quarter was primarily pushed by the upper income degree in comparison with the comparability interval.”
Full-year income elevated by 17.5 % to €59.5 million, whereas EBITDA totaled €11.3 million. The corporate recorded an working lack of €14.9 million over the identical interval—a rise on the €4.3 million working loss recorded in the course of the earlier fiscal yr.
Assessing the corporate’s long-term enterprise prospects, Maki mentioned Treatment stays dedicated to self-publishing its personal titles and evolving right into a “extremely regarded inventive studio with sustainable, important business success” by 2030.
Source link
#Control #topped #sales #attracted #20M #players
